iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
140.15
-0.21 (-0.15%)
Sep 4, 2025, 3:08 PM - Market open
IBB Holdings Information
IBB is an equity ETF with a total of 256 individual holdings. The top holdings are Gilead Sciences stock at 7.16%, Amgen at 6.96%, Regeneron Pharmaceuticals at 6.42%, Vertex Pharmaceuticals at 6.34%, and Alnylam Pharmaceuticals at 5.95%.
Total Holdings
256
Top 10 Percentage
47.47%
Asset Class
Equity
ETF Category
Health
Assets
5.49B
PE Ratio
18.93
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 7.16% |
| 2 | AMGN | Amgen Inc. | 6.96% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 6.42% |
| 4 | VRTX | Vertex Pharmaceuticals Incorporated | 6.34% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.95% |
| 6 | IQV | IQVIA Holdings Inc. | 3.37% |
| 7 | INSM | Insmed Incorporated | 3.21% |
| 8 | ARGX | argenx SE | 2.90% |
| 9 | MTD | Mettler-Toledo International Inc. | 2.82% |
| 10 | NTRA | Natera, Inc. | 2.34% |
| 11 | BIIB | Biogen Inc. | 2.18% |
| 12 | ONC | BeOne Medicines AG | 1.98% |
| 13 | UTHR | United Therapeutics Corporation | 1.90% |
| 14 | WAT | Waters Corporation | 1.88% |
| 15 | INCY | Incyte Corporation | 1.75% |
| 16 | BNTX | BioNTech SE | 1.61% |
| 17 | ILMN | Illumina, Inc. | 1.61% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 1.45% |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 1.19% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.18% |
| 21 | GMAB | Genmab A/S | 1.12% |
| 22 | EXEL | Exelixis, Inc. | 1.05% |
| 23 | HALO | Halozyme Therapeutics, Inc. | 0.95% |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 0.95% |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.94% |
As of Sep 2, 2025